Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
UE LifeSciences eyes recurring revenue model for cancer detector
Medical devices maker UE LifeSciences Inc plans to sell in India a portable, hand-held device to detect breast cancer, as ......
Healthcare
Metropolis in talks for a bunch of M&As: Ameera Shah
Mumbai-based pathology chain operator Metropolis Healthcare has recently seen one of its co-promoters selling out to private equity firm Carlyle. ......
Healthcare
Pfizer to sell Thane plant for $27M
The Indian arm of drug maker Pfizer Inc has agreed to sell its Thane plant to a little-known firm for ......
Healthcare
Fortis co-promoter gives up executive role to join sect
Shivinder Singh, billionaire co-promoter of Religare and Fortis Group, is to step down from active business life to join religious ......
Healthcare
Serum Institute defers stake sale plan
Serum Institute of India Ltd, the world’s fifth-largest vaccines maker by volume and the largest in Asia, has postponed its ......
Healthcare
Vyome Biosciences' flagship product to start clinical trials
Delhi-based biopharmaceutical firm Vyome Biosciences Pvt Ltd said it will start clinical trials for its flagship acne product in the ......
Healthcare
BCCL's Springboard backs healthcare trainer VIVO
Gurgaon-based healthcare training and education firm VIVO Healthcare Ltd has raised an undisclosed amount of funding from Springboard Ventures, an ......
Healthcare
Sun Pharma to sell two Ranbaxy units to Strides
India's top drugmaker Sun Pharmaceutical Industries Ltd has signed an agreement with Strides Arcolab Ltd to sell the erstwhile Ranbaxy’s ......
Healthcare
Portea raises $37.5M from Accel, IFC & others
Health Vista India Pvt Ltd, that runs home healthcare company Portea Medical, has raised $37.5 million (Rs 247 crore) in ......
Healthcare
Fortis to sell Dubai pathology business
Fortis Healthcare Ltd, the second-largest hospital chain in the country, is evaluating proposals for the sale of its pathology business ......
